![Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy](https://www.mdpi.com/cancers/cancers-14-02374/article_deploy/html/images/cancers-14-02374-g001a.png)
Cancers | Free Full-Text | Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
![performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram](https://www.researchgate.net/publication/10978140/figure/tbl2/AS:601775400820743@1520485844541/performance-of-PSA-density-with-respect-to-multiple-cutoff-levels-Note-the-unacceptable.png)
performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram
![Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-017-0024-7/MediaObjects/41391_2017_24_Fig1_HTML.jpg)
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer | Prostate Cancer and Prostatic Diseases
![Cancers | Free Full-Text | Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI Cancers | Free Full-Text | Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI](https://www.mdpi.com/cancers/cancers-14-02702/article_deploy/html/images/cancers-14-02702-g001-550.jpg)
Cancers | Free Full-Text | Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
![Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2021204112/asset/images/medium/radiol.2021204112.va.gif)
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
![Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study](https://www.frontiersin.org/files/Articles/693684/fonc-11-693684-HTML/image_m/fonc-11-693684-g001.jpg)
Frontiers | PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
![Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/a46107e3-2124-46ce-a2e7-7c48cf9f8ca2/gr1_lrg.jpg)
Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus
![When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/02/tnpcil2.png)